FRP2370 Citations (2)
Originally described in: A precisely adjustable, variation-suppressed eukaryotic transcriptional controller to enable genetic discovery.Azizoglu A, Brent R, Rudolf F Elife. 2021 Aug 3;10. pii: 69549. doi: 10.7554/eLife.69549. PubMed Journal
Articles Citing FRP2370
| Articles |
|---|
| Development of a yeast whole-cell biocatalyst for MHET conversion into terephthalic acid and ethylene glycol. Loll-Krippleber R, Sajtovich VA, Ferguson MW, Ho B, Burns AR, Payliss BJ, Bellissimo J, Peters S, Roy PJ, Wyatt HDM, Brown GW. Microb Cell Fact. 2022 Dec 31;21(1):280. doi: 10.1186/s12934-022-02007-9. PubMed |
Autorepression-Based Conditional Gene Expression System in Yeast for Variation-Suppressed Control of Protein Dosage.
Azizoglu A, Loureiro C, Venetz J, Brent R.
Curr Protoc. 2023 Jan;3(1):e647. doi: 10.1002/cpz1.647.
PubMed
Associated Plasmids |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.